Rosa & Co

Dr. Schoeberl will present “Using Mathematical Models To Set Design Criteria For Antibody-Based Therapies” April 17, 2012.

Rosa to Present The MQM Standard and Lead Optimization Using Systems Pharmacology Modeling

Rosa Workshop Presents The MQM Quality Standard For Mechanistic Modeling

PK/PD analyses used to support the rationale for therapeutic strategies targeting myostatin pathway

Series of Seminars and Workshops to be held in 2012 across the US and in Europe

Collaboration will combine Rosa’s PhysioPD™ modeling & simulation capabilities with Biopontis’ innovative asset sourcing and financial structure to improve early drug development productivity

Integration Creates Seamless Data Management and Analysis Capability for ARA Customers

Alliance combines innovative exploratory study design, leading in silico drug development capabilities, and a global licensing network to increase the value of emerging company portfolios and address pipeline gaps for established drug manufacturers.

You are invited to attend Dr. Goburru’s webinar The “Learn & Apply” Paradigm in Drug Development on April 18, 2011 at 1:00 pm EST (GMT -5:00). This talk will summarize applying drug-disease-trial modeling to decision-making in drug development.